9P BRCA1 promoter methylation confers a more favorable prognosis to systemically untreated young triple-negative breast cancer patients than tumour BRCA1 mutation
Titel:
9P BRCA1 promoter methylation confers a more favorable prognosis to systemically untreated young triple-negative breast cancer patients than tumour BRCA1 mutation
Auteur:
Wang, Y. Rosenberg, E.H. Dackus, G.M.H.E. Broeks, A. Cornelissen, S. van Diest, P.J. Hauptmann, M. Ter Hoeve, N. De Jong, V. Jozwiak, K. Koop, E. Nederlof, P.M. Opdam, M. Siesling, S. Stathonikos, N. Voogd, A. Vreuls, W. Kok, M. Linn, S.C. Schmidt, M.K.